Page last updated: 2024-11-07

2-acetylaminofluorene and Liver Steatosis

2-acetylaminofluorene has been researched along with Liver Steatosis in 1 studies

2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.

Research Excerpts

ExcerptRelevanceReference
" Groups of 28 week old DIO and LEAN mice were dosed with the bioactivation-dependent DNA-reactive hepatocarcinogen 2-acetylaminofluorene (AAF), at 2."1.39Hepatocellular proliferation and hepatocarcinogen bioactivation in mice with diet-induced fatty liver and obesity. ( Duan, JD; Hayes, AN; Iatropoulos, MJ; Jeffrey, AM; Leach, MW; Stedman, NL; Williams, GM, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iatropoulos, MJ1
Duan, JD1
Jeffrey, AM1
Leach, MW1
Hayes, AN1
Stedman, NL1
Williams, GM1

Other Studies

1 other study available for 2-acetylaminofluorene and Liver Steatosis

ArticleYear
Hepatocellular proliferation and hepatocarcinogen bioactivation in mice with diet-induced fatty liver and obesity.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2013, Volume: 65, Issue:4

    Topics: 2-Acetylaminofluorene; Animal Feed; Animals; Carcinogens; Cell Proliferation; Diet, Fat-Restricted;

2013